Drug discovery: A historical perspective

Science

Volumn 287, Issue 5460, 2000, Pages 1960-1964

  Drews, Jürgen ^a  

^a Basel Switzerland and Orbimed A   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBUTAMIDE; DIAZOXIDE; DICLOFENAMIDE; DIURETIC AGENT; FUROSEMIDE; SULFADIAZINE; SULFAMIDOCHRYSOIDINE; SULFANILAMIDE DERIVATIVE; SULFATHIAZOLE; SULFONAMIDE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

BIOTECHNOLOGY; DRUG INDUSTRY; DRUG RESEARCH; DRUG STRUCTURE; GENE TECHNOLOGY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW;

CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; MOLECULAR BIOLOGY; PHARMACOLOGY, CLINICAL; PORTRAITS; TECHNOLOGY, PHARMACEUTICAL;

EID: 0034677966     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.287.5460.1960     Document Type: Review

References (63)

1. J. Drews, in Quest of Tomorrow's Medicines (Springer-Verlag, New York, 1999), pp. 51-68.
2. F. J. Moore, A History of Chemistry (McGraw-Hill, New York, 1918), pp. 212-220.
3. A. M. Roberts, Serendipity (Wiley, New York, 1989), pp. 66-74.
4. P. Ehrlich, in Gesammelte Arbeiten, F. Himmelweit, Ed. (Springer-Verlag, Berlin, 1957).
5. F. W. Sertürner, Gilbert's Annalen d. Physik 25, 56 (1817).
6. W. Sneader, Drug Discovery (Wiley, New York, 1985).
7. E. Farber, The Evolution of Chemistry; a History of Its Ideas, Methods, and Materials, L Fiebiger, Ed. (Ronald Press, New York, 1952), pp. 173-188.
8. J. Koch-Weser and P. J. Schechter, Life Sci. 22, 1361 (1978).
9. H. C. Peyer, Roche-Geschichte einer Unternehmung, 1896-1996 (Roche, Basel, 1996).
10. E. Chain et al., Lancet 1, 226 (1940).
11. A. Fleming, Br. J. Exp. Pathol. 10, 226 (1940).
12. H. R. Taylor, Int. Ophthalmol. 2, 83 (1987).
13. A. W. Alberts, Am. J. Cardiol. 15, 10J (1988).
14. D. J. G. White, Ed., Proceedings of an International Conference on Cyclosporin A (Elsevier, Amsterdam, 1982), pp. 5-19.
15. H. Tanaka et al., Yakugaku Zasshi 8, 542 (1997).
16. N. U. Meldrum and F. J. Roughton, J. Physiol. 80, 113 (1933).
17. W. B. Schwartz, N. Engl. J. Med. 240, 173 (1949).
18. R. A. Maxwell and S. B. Eckhardt, Drug Discovery: A Casebook and Analysis (Humana, Clifton, NJ, 1990).
19. J. N. Langley, J. Physiol. (London) 33, 374 (1905)
20. R. P. Ahlquist, Am. J. Physiol. 1, 100 (1948).
21. J. W. Black, in Drug Responses in Man (CIBA Foundation Symposium, Basel, Switzerland, 1967), pp. 111-117.
22. Z. Bacq, in Discoveries in Pharmacology, M. J. Parham and J. Braunfels, Eds. (Elsevier, Amsterdam, 1983), vol. 1, pp. 49-101.
23. W. Hunkeler et al., Nature 290, 514 (1981).
24. C. Buske et al., Eur. J. Cancer 4, 549 (1999).
25. J. Drews, in Human Disease - From Genetic Causes to Biochemical Effects, J. Drews and St. Ryser, Eds. (Blackwell, Berlin, 1997), pp. 5-9.
26. J. Drews and St. Ryser, Classic Drug Targets. Special Pullout [Nature Biotechnol. 15 (1997)].
27. I. Zipkin and A. Michael, BioCentury 7, 1 (1999).
28. M. S. Cragg et al., Curr. Opin. Immunol. 5, 541 (1999).
29. J. Drews, Drug Discovery Today 3, 491 (1998).
30. G. Köhler and C. Milstein, Nature 256, 495 (1975).
31. G. Winter and W. J. Harris, Trends Pharmacol. Sci. 14, 139 (1993).
32. C. Queen et al., Proc. Natl. Acad. Sci. U.S.A. 86, 10029 (1989).
33. M. Bruggemann and M. S. Neuberger, Immunol. Today 8, 391 (1996).
34. W. D. Huse et al., Science 246, 1275 (1989).
35. H. R. Hoogenboom et al., Immunotechnology 4, 1 (1998).
36. D. J. Rodi and L Makowski, Curr. Opin. Biotechnol. 10, 87 (1999)
37. S. Wright, Evolution and the Genetics of Populations: Genetic and Biometric Foundations (Univ. of Chicago Press, Chicago, IL, 1984).
38. P. J. Guillauseau, D. Tielmans, M. Virally-Monod, M. Assayag, Diabetes Metab. 23 (Suppl. 2), 14 (1997).
39. R. A. Shimkets and R. P. Lifton, Curr. Opin. Nephrol. Hypertens. 2, 162(1996).
40. J. Drews and St. Ryser, Drug Discovery Today 2, 365 (1997).
41. M. Sills, personal communication.
42. J. Drews and St. Ryser, Drug Inf. J. 30, 97 (1996).
43. J. Drews, Drug Discovery Today 3, 491 (1998).
44. R. Lahana, Drug Discovery Today 4, 447 (1999).
45. T. U. Mayer et al., Science 286, 971 (1999).
46. B. A. Foster et al., Science 286, 2507 (1999).
47. J. Aramburu et al., Science 285, 2129 (1999).
48. S. M. Haffner, L. A. Mykkanen, C. C. Gonzalez, M. P. Stern, Int. J. Obes. Rel. Metab. Disord. 7, 695 (1998).
49. M. M. Hussain, D. K. Strickland, A. Bakillah, Annu. Rev. Nutr. 19, 141 (1999).
50. E. Sakiniene, B. Heyman, A. Tarkowski, Scand. J. Immunol. 3, 250 (1999).
51. L. Chouchane et al., Int. Arch. Allergy Immunol. 120, 50 (1999).
52. St. Ligget in preparation.
53. J. A. Kuivenhoven et al., N. Engl. J. Med. 338, 86 (1998).
54. St. L. Dixon and H. O. Villar, J. Chem. Inf. Comp. Sci. 38, 1192 (1998).
55. L. M. Kauvar et al., Chem. Biol. 2, 107 (1995).
56. St. K. Burley et al., Nature Genet. 23, 151 (1999).
57. P. F. Lindley, Acta Crystaltogr. D. 55, 1654 (1999).
58. S. E. Brenner, C. Chothia, T. Hubbard, Curr. Opin. Struct. Biol. 7, 369 (1997).
59. J. A. Wells et al., Recent Prog. Hormone Res. 48, 253 (1993).
60. K. D. Stigers, M. J. Soth, J. S. Nowick, Curr. Opin. Chem. Biol. 6, 714 (1999).
61. T. Clackson and J. A. Wells, Science 267, 383 (1995).
62. L. S. Goodman et al., Eds., Goodman and Gilman's The Pharmacological Basis of Therapeutics (McGraw-Hill, New York, ed. 9, 1996).
63. I am indebted to J. Curtis for doing the illustrations.